Clinical trial
Neoadjuvant Immunotherapy And Chemotherapy Followed By Concurrent Chemoradiation Or Organ Preservation Surgery In Locally Advanced Laryngeal Cancer And Hypopharyngeal Cancer
NCT06039631 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neoadjuvant Immunotherapy And Chemotherapy Followed By Concurrent Chemoradiation Or Organ Preservation Surgery In Locally Advanced Laryngeal Cancer And Hypopharyngeal Cancer
- Lead sponsor
- Fudan University
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- August 22, 2023
- Completion date
- September 1, 2029
- Enrollment
- 82 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypopharyngeal cancer, larynx cancer